Alpine Immune Sciences (NASDAQ: ALPN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.190 | -0.250 | -0.0600 | ||||
REV | 13.629M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Alpine Immune Sciences (NASDAQ: ALPN) through any online brokerage.
Other companies in Alpine Immune Sciences’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Burning Rock Biotech (NASDAQ:BNR), LianBio (NASDAQ:LIAN) and PepGen (NASDAQ:PEPG).
The latest price target for Alpine Immune Sciences (NASDAQ: ALPN) was reported by HC Wainwright & Co. on Monday, December 21, 2020. The analyst firm set a price target for 21.00 expecting ALPN to rise to within 12 months (a possible 143.90% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Alpine Immune Sciences (NASDAQ: ALPN) is $8.61 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Alpine Immune Sciences.
Alpine Immune Sciences’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Alpine Immune Sciences.
Alpine Immune Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.